Microsoft Windows Workflow Foundation 40 Cookbook

por Zhu, Andrew
Publicado 2010

Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?

por Zhu, Andrew X
Publicado 2009

Targeting insulin-like growth factor axis in hepatocellular carcinoma

por Wu, Jennifer, Zhu, Andrew X
Publicado 2011

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets

por Chong, Dawn Q., Zhu, Andrew X.
Publicado 2016

Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities

por Hack, Stephen P., Zhu, Andrew X., Wang, Yulei
Publicado 2020

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise

por Saha, Supriya K., Zhu, Andrew X., Fuchs, Charles S., Brooks, Gabriel A.
Publicado 2016

Return to Sport After Hip Resurfacing Arthroplasty

por Morse, Kyle W., Premkumar, Ajay, Zhu, Andrew, Morgenstern, Rachelle, Su, Edwin P.
Publicado 2021

Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic...

por Lee, Sang Ho, Hayano, Koichi, Zhu, Andrew X., Sahani, Dushyant V., Yoshida, Hiroyuki
Publicado 2015

Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab

por Efe, Orhan, Goyal, Lipika, Galway, Aralee, Zhu, Andrew X., Niles, John L., Zonozi, Reza
Publicado 2021

Stigmatising and Racialising COVID-19: Asian People’s Experience in New Zealand

por Liu, Liangni Sally, Jia, Xiaoyun, Zhu, Andrew, Ran, Guanyu Jason, Siegert, Richard, French, Nigel, Johnston, David
Publicado 2022

Poster 218: Biomechanical Function of the Lateral Meniscus Posterior Root and Meniscofemoral Ligaments: A Computational Study

por Ahsan, Zahab, Razu, Swithin, Zhu, Andrew, Jahandar, Hamid, Imhauser, Carl, Wickiewicz, Thomas, Nawabi, Danyal, Pearle, Andrew, Patel, Ronak
Publicado 2022

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

por Goulart, Bernardo HL, Clark, Jeffrey W, Lauwers, Gregory Y, Ryan, David P, Grenon, Nina, Muzikansky, Alona, Zhu, Andrew X
Publicado 2009

A Multicenter Retrospective Study on Clinical Characteristics, Treatment Patterns, and Outcome in Elderly Patients with Hepatocellular Carcinoma

por Kozyreva, Olga N., Chi, Dorcas, Clark, Jeffrey W., Wang, Hejing, Theall, Kathy P., Ryan, David P., Zhu, Andrew X.
Publicado 2011

The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway

por Zhu, Andrew, Ying, Xiaohan, Pean, Christian A., Sheth, Neil P., Cross, Michael B., Gonzalez Della Valle, Alejandro, Premkumar, Ajay
Publicado 2022

Measuring the missing: Knowledge, risk perceptions and self-protection practices of COVID-19 among the Asian population in New Zealand: An online survey

por Liu, Liangni Sally, Jia, Xiaoyun, Zhu, Andrew, Ran, Guanyu Jason, Johnston, David, Siegert, Richard, Gong, Yuan, French, Nigel, Lu, Jun
Publicado 2023

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

por Sahani, Dushyant V, Jiang, Tao, Hayano, Koichi, Duda, Dan G, Catalano, Onofrio A, Ancukiewicz, Marek, Jain, Rakesh K, Zhu, Andrew X
Publicado 2013

Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review

por Zhu, Andrew, Zakusilo, George, Lee, Matthew S., Kim, Julie, Kim, Hyejin, Ying, Xiaohan, Chen, Yu Han, Jedlicka, Caroline, Mages, Keith, Choi, Justin J.
Publicado 2021

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

por Hack, Stephen P., Verret, Wendy, Mulla, Sohail, Liu, Bo, Wang, Yulei, Macarulla, Teresa, Ren, Zhenggang, El-Khoueiry, Anthony B., Zhu, Andrew X.
Publicado 2021

Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbr...

por Kudo, Masatoshi, Finn, Richard S., Cheng, Ann-Lii, Zhu, Andrew X., Ducreux, Michel, Galle, Peter R., Sakamoto, Naoya, Kato, Naoya, Nakano, Michitaka, Jia, Jing, Vogel, Arndt
Publicado 2023

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis

por Park, Joon Oh, Ryoo, Baek-Yeol, Yen, Chia-Jui, Kudo, Masatoshi, Yang, Ling, Abada, Paolo B., Cheng, Rebecca, Orlando, Mauro, Zhu, Andrew X., Okusaka, Takuji
Publicado 2016